Evidence map›Paper›PMID 31240210›Full record

ArticleBioMed research international2019

Galangin Suppresses Renal Inflammation via the Inhibition of NF-

Hao Lu, Hui Yao, Rong Zou, Xiwen Chen, Hanlin Xu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Frontiers in nutrition · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hao LuSchool of Pharmaceuticals, Hubei University of Chinese Medicine, No. 1 HuangJiaHu Road West, Hongshan District, Wuhan 430065, China.
Hui YaoSchool of Pharmaceuticals, Hubei University of Chinese Medicine, No. 1 HuangJiaHu Road West, Hongshan District, Wuhan 430065, China.
Rong ZouSchool of Pharmaceuticals, Hubei University of Chinese Medicine, No. 1 HuangJiaHu Road West, Hongshan District, Wuhan 430065, China.
Xiwen ChenSchool of Pharmaceuticals, Hubei University of Chinese Medicine, No. 1 HuangJiaHu Road West, Hongshan District, Wuhan 430065, China.
Hanlin XuSchool of Pharmaceuticals, Hubei University of Chinese Medicine, No. 1 HuangJiaHu Road West, Hongshan District, Wuhan 430065, China.ORCID 0000-0001-5669-8098
Hubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal inflammation can result in renal injury. Uric acid (UA) is the final product of purine metabolism in humans and because of the lack of urate oxidase, UA may accumulate in tissues, including kidney, causing inflammation. Galangin was isolated from a traditional Chinese medicine plant and possesses several beneficial effects, working as an anti-oxidant, anti-mutagenic, anti-tumor, anti-inflammatory, anti-microbial, and anti-viral agent. Therefore, this study aimed at investigating the molecular mechanism of galangin in the attenuation of UA induced renal inflammation in normal rat kidney epithelial cells NRK-52E. Our findings suggested that galangin treatment efficiently protected NRK-52E cells against UA induced renal inflammation by decreasing tumor necrosis factor (TNF)-

Indexed as

AnimalsCell LineCyclooxygenase 2CytokinesDinoprostoneEpithelial CellsFlavonoidsInflammasomesInflammationInterleukin-18Interleukin-1betaNephritisNF-kappa BNitric OxideNitric Oxide SynthaseNLR Family, Pyrin Domain-Containing 3 ProteinCyclooxygenase 2CytokinesDinoprostoneFlavonoidsgalanginInflammasomesInterleukin-18Interleukin-1betaNF-kappa BNitric OxideNitric Oxide SynthaseNLR Family, Pyrin Domain-Containing 3 ProteinNMRK1 protein, humanPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-aktTumor Necrosis Factor-alphaUric Acid

Identifiers

PMID31240210
PMCPMC6556363
OpenAlexW2944845438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.